Jan Kristian Jensen

Title: Innovations by Jan Kristian Jensen

Introduction

Jan Kristian Jensen is a notable inventor based in Randers, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of Complement Factor I (CFI) variants. His work focuses on improving the characteristics of CFI, which plays a crucial role in the complement system of the immune response.

Latest Patents

Jan Kristian Jensen holds a patent for "Complement factor I-related compositions and methods." This patent includes CFI variants that exhibit at least one improved characteristic relative to wild type CFI. The CFI variants can demonstrate tunable specificity and activity. Additionally, the patent covers CFI-containing fusion constructs, which comprise at least one domain of CFI, such as wild type full-length CFI fused to human serum albumin. These innovations may be beneficial for treating diseases or conditions associated with dysregulation of the complement system or a deficiency of CFI.

Career Highlights

Jan Kristian Jensen is currently employed at Vertex Pharmaceuticals, Inc., where he continues to advance his research in biotechnology. His work has the potential to impact therapeutic approaches for various medical conditions.

Collaborations

Throughout his career, Jan has collaborated with esteemed colleagues, including Grant E Blouse and Brajesh Kumar. These partnerships have contributed to the development and refinement of his innovative research.

Conclusion

Jan Kristian Jensen's contributions to the field of biotechnology, particularly through his patent on Complement Factor I variants, highlight his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.